Jeffrey D. Rothstein MD, PhD

Professor of Neurology and Neuroscience; Director Brain Science Institute, Johns Hopkins University

Jeffrey D. Rothstein, M.D., Ph.D. is the John W. Griffin Director for the Brain Science Institute, as well as a Professor of Neurology and Neuroscience, and the Founding Director of the Robert Packard Center for ALS Research at Johns Hopkins University School of Medicine. He is a clinician scientist studying ALS pathophysiology, astrocyte/oligodendroglial biology and therapy discovery; His research lead to the first successful, FDA-approved drug to slow ALS. Recently he has defined the defect in nuclear transport/pores that underlie a large percentage of ALS, Huntington’s disease and Alzheimer’s dementia patients. In addition to running an ALS clinic at Johns Hopkins, he also runs a Brain Science Institute drug discovery group to identify novel therapeutics for neurological and psychiatric disease.